Repligen Corp (NASDAQ: RGEN) on Monday, soared 3.73% from the previous trading day, before settling in for the closing price of $111.94. Within the past 52 weeks, RGEN’s price has moved between $106.78 and $182.52.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 23.47% over the past five years. The company achieved an average annual earnings per share of 7.97%. With a float of $53.02 million, this company’s outstanding shares have now reached $56.09 million.
Let’s look at the performance matrix of the company that is accounted for 1778 employees. In terms of profitability, gross margin is 48.69%, operating margin of -6.5%, and the pretax margin is -5.17%.
Repligen Corp (RGEN) Insider Updates
Observing investor behavior towards Medical Instruments & Supplies industry stocks is more important than anything else. The insider ownership of Repligen Corp is 5.57%, while institutional ownership is 100.74%. The most recent insider transaction that took place on Mar 17 ’25, was worth 4,080,663. In this transaction Director of this company sold 26,756 shares at a rate of $152.51, taking the stock ownership to the 136,301 shares. Before that another transaction happened on Mar 17 ’25, when Company’s Director bought 250 for $150.69, making the entire transaction worth $37,672. This insider now owns 1,043 shares in total.
Repligen Corp (RGEN) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.42 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 7.97% per share during the next fiscal year.
Repligen Corp (NASDAQ: RGEN) Trading Performance Indicators
Repligen Corp (RGEN) is currently performing well based on its current performance indicators. A quick ratio of 7.28 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 10.28. Likewise, its price to free cash flow for the trailing twelve months is 44.81.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.46, a number that is poised to hit 0.35 in the next quarter and is forecasted to reach 2.24 in one year’s time.
Technical Analysis of Repligen Corp (RGEN)
Repligen Corp (NASDAQ: RGEN) saw its 5-day average volume 1.23 million, a positive change from its year-to-date volume of 0.7 million. As of the previous 9 days, the stock’s Stochastic %D was 17.22%. Additionally, its Average True Range was 8.93.
During the past 100 days, Repligen Corp’s (RGEN) raw stochastic average was set at 16.53%, which indicates a significant decrease from 29.86% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 55.52% in the past 14 days, which was lower than the 56.13% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $149.41, while its 200-day Moving Average is $145.36. Nevertheless, the first resistance level for the watch stands at $124.31 in the near term. At $132.52, the stock is likely to face the second major resistance level. The third major resistance level sits at $143.19. If the price goes on to break the first support level at $105.43, it is likely to go to the next support level at $94.76. Assuming the price breaks the second support level, the third support level stands at $86.55.
Repligen Corp (NASDAQ: RGEN) Key Stats
Market capitalization of the company is 6.52 billion based on 56,149K outstanding shares. Right now, sales total 634,440 K and income totals -25,510 K. The company made 174,150 K in profit during its latest quarter, and -30,280 K in sales during its previous quarter.
